SEC Form 4 · accession 0001061983-26-000088
CYTOKINETICS INC · CYTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fady Ibraham Malik
Officer — EVP Research & Development
Period of report
Aug 18, 2026
Accepted (ET)
Aug 18, 2026 · 4:38 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001061983
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 18, 2026 | M | 3,500 | $7.80 | A | 157,402 | D | |
| Common Stock | Aug 18, 2026 | S | 3,500 | $75.82 | D | 153,902 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (Right to Buy) | $7.80 | Aug 18, 2026 | M | 3,500 | D | Mar 27, 2018 | Feb 27, 2028 | Common Stock | 3,500 | 30,386 | D |